19-OCT-1987 11:04:10.38

RORER <ROR> UNIT CLOTTING DRUG APPROVED

Rorer Group Inc's Armour Pharmaceutical Co said it received Food and Drug Administration approval for a blood clotting drug for hemophiliacs.     The company said the drug, monoclate antihemophilic factor, will treat hemophilia A, the most common form of hereditary blood clotting disorder.     Monoclate is 99 pct free of unwanted contaminants, compared to other blood products which are less than one pct pure, Armour said.  Reuter &#3;

